|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―May―11 |
Letter: paying attention to the comorbidities or extraintestinal complications in patients with inflammatory bowel disease during the
COVID
-19 pandemic |
Wen-Qiang Yuan, Fei Li, Liu-Chan Yang, Zai-Li Yang, De-Jun Cui |
2 |
[GO] |
2022―Apr―16 |
Letter: association between COVID-19 and inflammatory bowel disease |
Hui-Yuan Chen, Shiow-Ing Wang, Renin Chang, James Cheng-Chung Wei |
3 |
[GO] |
2022―Apr―01 |
Letter: inflammatory bowel disease services during the Covid-19 pandemic |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
4 |
[GO] |
2022―Apr―01 |
Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply |
Mohammed Deputy, Ailsa Hart, Omar Faiz |
5 |
[GO] |
2022―Mar―31 |
Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: A systematic review, meta-analysis and meta-regression |
Abhishek Bhurwal, Hemant Mutneja, Vikas Bansal, Akshay Goel, Shilpa Arora, Bashar Attar, et al. (+5) Carlos D. Minacapelli, Gursimran Kochhar, Lea Ann Chen, Steve Brant, Darren Seril |
6 |
[GO] |
2022―Feb―08 |
The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study |
Mohammed Deputy, Kapil Sahnan, Guy Worley, Komal Patel, Violeta Balinskaite, Alex Bottle, et al. (+4) Paul Aylin, Elaine M Burns, Ailsa Hart, Omar Faiz |
7 |
[GO] |
2021―Dec―14 |
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: Propensity matched research network analysis |
Yousaf Hadi, Parambir S. Dulai, Justin Kupec, Nabeeha Mohy-Ud-Din, Vipul Jairath, Francis A. Farraye, Gursimran S. Kochhar |
8 |
[GO] |
2021―Dec―09 |
Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments |
Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, Vana Spoulou, Gkikas Magiorkinis, Ioannis Trontzas, et al. (+4) Panagiotis Trontzas, Garyphallia Poulakou, Konstantinos Syrigos, Giorgos Bamias |
9 |
[GO] |
2021―Oct―25 |
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study |
Cristina Bezzio, Alessandro Armuzzi, Federica Furfaro, Sandro Ardizzone, Monica Milla, Sonia Carparelli, et al. (+65) Ambrogio Orlando, Flavio Andrea Caprioli, Fabiana Castiglione, Chiara Viganò, Davide Giuseppe Ribaldone, Fabiana Zingone, Rita Monterubbianesi, Nicola Imperatore, Stefano Festa, Marco Daperno, Ludovica Scucchi, Antonio Ferronato, Luca Pastorelli, Paola Balestrieri, Chiara Ricci, Maria Cappello, Carla Felice, Gionata Fiorino, Simone Saibeni, Francesca Coppini, Patrizia Alvisi, Viviana Gerardi, Angela Variola, Silvia Mazzuoli, Marco Vincenzo Lenti, Daniela Pugliese, Mariangela Allocca, Francesca Ferretti, Jenny Roselli, Fabrizio Bossa, Alessandra Giuliano, Nicole Piazza, Gianpiero Manes, Alessandro Sartini, Andrea Buda, Federica Micheli, Valeria Ciardo, Giovanni Casella, Angelo Viscido, Giorgia Bodini, Valentina Casini, Alessandra Soriano, Arnaldo Amato, Laurino Grossi, Sara Onali, Matteo Rottoli, Rocco Spagnuolo, Stefania Baroni, Claudio Camillo Cortelezzi, Monia Baldoni, Marta Vernero, Franco Scaldaferri, Giovanni Maconi, Alessia Dalila Guarino, Andrea Palermo, Renata D’Incà, Maria Lia Scribano, Livia Biancone, Lucio Carrozza, Marta Ascolani, Francesco Costa, Antonio Di Sabatino, Irene Zammarchi, Matteo Gottin, Francesco Simone Conforti |
10 |
[GO] |
2021―Sep―26 |
Letter: the BSG COVID-19 interim coeliac disease guidance no-biopsy approach is safe in adults |
Lina Bourhan Tashtoush, Nicholas Charles Bosanko, Samuel Robin Broad, Ying Jenny Chan, Natasha Singhal, Sharon Saji, et al. (+5) Nissy Saju, Anusha Shah, Ansab Zulfiqar, Melina Ilarionos, Siba Prosad Paul |
11 |
[GO] |
2021―Sep―02 |
Review Article: Vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic |
Jayne Doherty, Sean Fennessy, Roisin Stack, Neil O’ Morain, Garret Cullen, Elizabeth J. Ryan, et al. (+2) Cillian De Gascun, Glen A. Doherty |
12 |
[GO] |
2021―Jun―25 |
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use? |
Dali Fan, Richard B. Gearry |
13 |
[GO] |
2021―Jun―10 |
Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study |
Antoine Meyer, Laura Semenzato, Mahmoud Zureik, Alain Weill, Franck Carbonnel, Rosemary Dray-Spira |
14 |
[GO] |
2020―Oct―07 |
Letter: population mortality from COVID-19 and latitude-data from China |
Nanyang Liu, Hao Li |
15 |
[GO] |
2020―Aug―31 |
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission |
Amarylle S. van Doorn, Berrie Meijer, Chris M. A. Frampton, Murray L. Barclay, Nanne K. H. de Boer |
16 |
[GO] |
2020―Aug―15 |
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with COVID-19 |
Gianluca Ianiro, Serena Porcari, Carlo Romano Settanni, Stefano Bibbò, Francesca Romana Ponziani, Lorenzo Zileri dal Verme, et al. (+3) Francesco Franceschi, Giovanni Cammarota, Antonio Gasbarrini |
17 |
[GO] |
2020―Aug―15 |
Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID-19 in the United Kingdom |
Mohammed Nabil Quraishi, Jonathan P. Segal, Rachel Cooney, Nicholas A. Kennedy, Rachel Ainley, Naveen Sharma, et al. (+2) Neeraj B. Bhala, Matthew J. Brookes |
18 |
[GO] |
2020―Aug―15 |
Letter: role of probiotics in the COVID-19 pandemic |
Enrik John T. Aguila, Marie Antoinette D. C. Lontok, Eliezer James T. Aguila |
19 |
[GO] |
2020―Aug―15 |
Letter: role of probiotics in the COVID-19 pandemic-authors' reply |
Yuan Tian, Long Rong |
20 |
[GO] |
2020―Aug―15 |
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? |
Rabia Deniz, Arif Atahan Çağatay, Ahmet Gül |
21 |
[GO] |
2020―Aug―15 |
Letter: is pneumococcal vaccination safe during the COVID-19 pandemic? Authors’ reply |
Aysha H. Al-Ani, Doug Johnson, Britt Christensen |
22 |
[GO] |
2020―Aug―15 |
Letter: prevalence and patterns of gastrointestinal symptoms in a large Western cohort of patients with coronavirus disease 2019-authors' reply |
Yuan Tian, Long Rong |
23 |
[GO] |
2020―Aug―15 |
Letter: immunotherapy in IBD patients in a SARS-CoV-2 endemic area |
Constanze H. Waggershauser, Cornelia Tillack-Schreiber, Christine Berchtold-Benchieb, Daniel Szokodi, Stefanie Howaldt, Thomas Ochsenkühn |
24 |
[GO] |
2020―Aug―15 |
Letter: immunotherapy for IBD patients in a SARS-CoV-2 endemic area-authors' reply |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba |
25 |
[GO] |
2020―Aug―10 |
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever |
Samantha Jane Benson-Pope, Richard B. Gearry |
26 |
[GO] |
2020―Aug―10 |
Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply |
Carlos Taxonera, Cristina Alba |
27 |
[GO] |
2020―Aug―10 |
Letter: IBD nurse-a pivotal role in the time of the pandemic |
Muhammad Umair Khan, Kamran Mushtaq, Khalid Mohsin A. A. Al-Ejji, Rafie A. Yakoob, Saad Rashid Alkaabi, Masoud Khoshnia |
28 |
[GO] |
2020―Aug―10 |
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors’ reply |
Aysha H. Al-Ani, Clarissa A. Rentsch, Sofia Azim, Emma Bidgood, Princy Onasseril, Britt Christensen |
29 |
[GO] |
2020―Jul―22 |
The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan |
Haijun Huang, Shanshan Chen, Hong Li, Xian-Long Zhou, Yining Dai, Wu Jia, et al. (+7) Jun Zhang, Lina Shao, Rong Yan, Mingshan Wang, Jiafeng Wang, Yuexing Tu, Minghua Ge |
30 |
[GO] |
2020―Jul―13 |
Letter: ACE2, Rho kinase inhibition and the potential role of vitamin D against COVID-19 |
Giovanni Bertoldi, Lisa Gianesello, Lorenzo A. Calò |
31 |
[GO] |
2020―Jul―13 |
Letter: liver disease and COVID-19-not the perfect storm |
Rooshi Nathwani, Sujit Mukherjee, Roberta Forlano, Benjamin H. Mullish, Nikhil Vergis, Nowlan Selvapatt, et al. (+4) Pinelopi Manousou, Shevanthi Nayagam, Maud Lemoine, Ameet Dhar |
32 |
[GO] |
2020―Jul―13 |
Letter: liver disease and COVID-19-not the perfect storm. Authors' reply” |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
33 |
[GO] |
2020―Jul―08 |
Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19 |
Anand V. Kulkarni, Pramod Kumar, Harsh Vardhan Tevethia, Madhumita Premkumar, Juan Pablo Arab, Roberto Candia, et al. (+5) Rupjyoti Talukdar, Mithun Sharma, Xiaolong Qi, Padaki Nagaraja Rao, Duvvuru Nageshwar Reddy |
34 |
[GO] |
2020―Jul―06 |
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients |
Francesca Romana Ponziani, Fabio Del Zompo, Antonio Nesci, Francesco Santopaolo, Gianluca Ianiro, Maurizio Pompili, Antonio Gasbarrini |
35 |
[GO] |
2020―Jun―25 |
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors’ reply |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey |
36 |
[GO] |
2020―May―20 |
Letter: does vitamin D have a potential role against COVID-19? |
Deepak Kumar, Prakamya Gupta, Dibyajyoti Banerjee |
37 |
[GO] |
2020―May―14 |
“Review article: COVID-19 and liver disease - what we know on 1st May 2020” |
Isabel Garrido, Rodrigo Liberal, Guilherme Macedo |
38 |
[GO] |
2020―May―14 |
Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity |
Jose Mansur |
39 |
[GO] |
2020―May―14 |
Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Authors' reply |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
40 |
[GO] |
2020―May―14 |
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic |
Samantha Jane Benson-Pope, Richard B. Gearry |
41 |
[GO] |
2020―May―14 |
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic-authors' reply |
Dominic Stephen King, Nigel John Trudgill, Nicola J. Adderley |
42 |
[GO] |
2020―May―14 |
Letter: does vitamin D have a potential role against COVID-19? Authors' reply |
Yuan Tian, Long Rong |
43 |
[GO] |
2020―May―06 |
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |
Mayur Garg, Simon G Royce, John S Lubel |
44 |
[GO] |
2020―May―02 |
2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases |
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey |
45 |
[GO] |
2020―Apr―30 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity. Authors' reply |
Mayur Garg, Aysha Al-Ani, Hannah Mitchell, Philip Hendy, Britt Christensen |
46 |
[GO] |
2020―Apr―29 |
Review Article: Prevention, Diagnosis and Management of COVID-19 in the Inflammatory Bowel Disease Patient |
Aysha Al-Ani, Ralley Prentice, Clarissa Rentsch, Doug Johnson, Zaid Ardalan, Neel Heerasing, et al. (+7) Mayur Garg, Sian Campbell, Joe Sasadeusz, Fin Macrae, Siew C. Ng, David T. Rubin, Britt Christensen |
47 |
[GO] |
2020―Apr―20 |
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North - supports vitamin D as a factor determining severity |
Jonathan M Rhodes, Sreedhar Subramanian, Eamon Laird, Rose Anne Kenny |
48 |
[GO] |
2020―Apr―14 |
Letter: Covid-19 and vitamin D-authors' reply |
Yuan Tian, Long Rong |
49 |
[GO] |
2020―Apr―13 |
Letter: Covid-19, and vitamin D |
Alba Panarese, Endrit Shahini |
50 |
[GO] |
2020―Mar―29 |
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission |
Yuan Tian, Long Rong, Weidong Nian, Yan He |